ESMO® 2025 Highlights: Presenter Vignette – Judith Quik
Judith Quik
MD, PhD Candidate
Netherlands Cancer Institute
2096MO
Systemic Therapy, Gastrectomy and CRS/HIPEC vs Systemic Therapy Alone for Gastric Cancer with Limited Peritoneal Dissemination: Results of the Randomised PERISCOPE II Trial.
Judith Quik
MD, PhD Candidate
Netherlands Cancer Institute
Johanna van Sandick
MD
Netherlands Cancer Institute
2096MO
Systemic Therapy, Gastrectomy and CRS/HIPEC vs Systemic Therapy Alone for Gastric Cancer with Limited Peritoneal Dissemination: Results of the Randomised PERISCOPE II Trial.
